What is Altimmune's debt-to-equity?

Altimmune (ALT) reported debt-to-equity of 0.1× in Q1 2026.

How has Altimmune's debt-to-equity changed year-over-year?

Altimmune's debt-to-equity increased by 7100.0% year-over-year, from 0× to 0.1×.

What is the long-term trend for Altimmune's debt-to-equity?

Over 5 years (2020 to 2025), Altimmune's debt-to-equity has grown at a 57.8% compound annual growth rate (CAGR), from 0× to 0.2×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

Altimmune ALT Debt-to-equity

Debt-to-equity at other companies

Eli LillyLLY

1.4×-1.1×

Merck & Co.MRK

1.1×+0.3×

Madrigal Pharmaceuticals, Inc.MDGL

0.7×+0.5×

Viking TherapeuticsVKTX

0×0.0×

Wave Life SciencesWVE

0×-0.1×

MeiraGTx Holdings plcMGTX

27.2×+26.1×

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Current ratio29.6×+13.7×

Where this comes from

Calculated from Altimmune’s reported figures.

total debt/total stockholders equity=0.1×

Based on the most recent quarter.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's debt-to-equity?: Altimmune (ALT) reported debt-to-equity of 0.1× in Q1 2026.
How has Altimmune's debt-to-equity changed year-over-year?: Altimmune's debt-to-equity increased by 7100.0% year-over-year, from 0× to 0.1×.
What is the long-term trend for Altimmune's debt-to-equity?: Over 5 years (2020 to 2025), Altimmune's debt-to-equity has grown at a 57.8% compound annual growth rate (CAGR), from 0× to 0.2×.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.